OPKO Health Inc (NYSE:OPK)
During the Trading Day
| 7.00 |  -0.16 / -2.23% |
Data as of 4:03pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 7.07 |  +0.07 / +1.00% |
Volume: 8,000.00 |
Latest OPK News | Press Releases
| Interesting OPK Put And Call For July 6:42pm / TheStreet.com | 'Mad Money' Lightning Round: Buy AOL Now May 15 / TheStreet.com |
Today’s Trading
| Previous close | 7.16 |
| Today’s open | 7.17 |
| Day’s range | 6.99 - 7.18 |
| Volume | 852,894 |
| Average volume (3 months) | 1,789,614 |
| Market cap | $2.4B |
| Dividend yield | -- |
Data as of 4:03pm ET, 05/20/2013
Growth & Valuation
| Earnings growth (last year) | -1,000.00% |
| Earnings growth (this year) | -109.09% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +68.14% |
| P/E ratio | NM |
| Price/Sales | 30.24 |
| Price/Book | 12.20 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| QCORQuestcor Pharmaceuti... | +0.27 | +0.72% |
| MYGNMyriad Genetics Inc | +0.13 | +0.39% |
| MDCOThe Medicines Co | -0.15 | -0.42% |
| TAROTaro Pharmaceutical ... | -0.23 | -0.36% |
Data as of 4:02pm ET, 05/20/2013
Financials
| Next reporting date | August 12, 2013 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $47.0M |
| Annual profit (last year) | -$29.0M |
| Net profit margin | -61.98% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Phillip Frost, MD |
Chief Financial Officer & Senior Vice President Juan F. Rodriguez, CPA |
Corporate headquarters Miami, Florida |
Forecasts
